Waiver Agreements in the Biotechnology Industry
101 Contracts & Agreements
- Adhera Therapeutics, Inc. (3 contracts)
- ADiTx Therapeutics, Inc. (3)
- AGENUS INC (2)
- Aldeyra Therapeutics, Inc. (1)
- Allarity Therapeutics, Inc. (6)
- Alpha Healthcare Acquisition Corp. (2)
- AMARIN CORP PLC (1)
- ARCA biopharma, Inc. (3)
- ARROWHEAD PHARMACEUTICALS, INC. (1)
- ARYA Sciences Acquisition Corp II (2)
- Axovant Sciences Ltd. (1)
- AzurRx BioPharma, Inc. (2)
- BIO-PATH HOLDINGS INC (1)
- BIOMARIN PHARMACEUTICAL INC (1)
- BRAINSTORM CELL THERAPEUTICS INC. (1)
- CATALYST BIOSCIENCES, INC. (6)
- Cellectar Biosciences, Inc. (1)
- Chardan Healthcare Acquisition Corp. (2)
- CLEVELAND BIOLABS INC (1)
- CTI BIOPHARMA CORP (1)
- CytoDyn Inc. (1)
- DYNAVAX TECHNOLOGIES CORP (1)
- FENNEC PHARMACEUTICALS INC. (1)
- Flexion Therapeutics Inc (1)
- FLUOROPHARMA MEDICAL, INC. (1)
- Fortress Biotech, Inc. (1)
- GENEREX BIOTECHNOLOGY CORP (3)
- Greater Cannabis Company, Inc. (1)
- GTX INC (2)
- HedgePath Pharmaceuticals, Inc. (4)
- HEMISPHERX BIOPHARMA INC (2)
- HERON THERAPEUTICS, INC. (2)
- International Stem Cell CORP (3)
- LA JOLLA PHARMACEUTICAL CO (2)
- Leisure Acquisition Corp. (2)
- MARIZYME INC (10)
- MERRIMACK PHARMACEUTICALS INC (1)
- NANOVIRICIDES, INC. (6)
- OPGEN INC (1)
- Orgenesis Inc. (1)
- PIERIS PHARMACEUTICALS, INC. (1)
- REXAHN PHARMACEUTICALS, INC. (1)
- Rich Pharmaceuticals, Inc. (1)
- RITTER PHARMACEUTICALS INC (3)
- SELLAS Life Sciences Group, Inc. (2)
- SPHERIX INC (1)
- Sun BioPharma, Inc. (2)
- TENAX THERAPEUTICS, INC. (1)
- VBI Vaccines Inc (1)
- ZAFGEN, INC. (1)
- Waiver and Redemption Agreement, dated December 18, 2024, between Fennec Pharmaceuticals Inc. and Petrichor Opportunities Fund I LP (FENNEC PHARMACEUTICALS INC., Filed With SEC on December 20, 2024)
- Waiver, by and among Panbela Therapeutics, Inc., Cancer Prevention, Pharmaceuticals, LLC and USWM, LLC. dated October 2, 2024 (Sun BioPharma, Inc., Filed With SEC on November 14, 2024)
- Waiver and Amendment, dated as of May 8, 2024, by and among Humacyte Global, Inc., Humacyte, Inc. and Hook SA LLC (Alpha Healthcare Acquisition Corp., Filed With SEC on August 13, 2024)
- Waiver by and among Panbela Therapeutics, Inc., Cancer Prevention, Pharmaceuticals, LLC and USWM, LLC, dated August 8, 2024 (Sun BioPharma, Inc., Filed With SEC on August 13, 2024)
- Waiver Agreement by and between Evofem Biosciences, Inc., Aditxt, Inc. and Adifem, Inc. dated July 12, 2024 (ADiTx Therapeutics, Inc., Filed With SEC on July 18, 2024)
- Waiver Letter, dated as of April 11, 2024, by Elliott Investment Management L.P., Elliott Associates, L.P. and Elliott International, L.P., to the Cooperation Agreement, dated as... (BIOMARIN PHARMACEUTICAL INC, Filed With SEC on April 26, 2024)
- Waiver, dated as of February 18, 2024, by and among Humacyte Global, Inc., Humacyte, Inc. and Hook SA LLC (Alpha Healthcare Acquisition Corp., Filed With SEC on March 28, 2024)
- Limited Waiver Agreement, dated as of February 13, 2024, by and between the Company and the Purchaser listed on the signature page attached thereto (Allarity Therapeutics, Inc., Filed With SEC on February 14, 2024)
- Form of Waiver and Consent, dated as of November 20, 2023, between Marizyme, Inc. and Univest Securities, LLC or its designee (MARIZYME INC, Filed With SEC on November 21, 2023)
- Waiver and Consent between Marizyme, Inc. and Pioneer Capital Anstalt, dated as of September 7, 2023 (MARIZYME INC, Filed With SEC on October 12, 2023)
- Waiver and Consent between Marizyme, Inc. and Alessandro Solimeo, dated as of July 21, 2023 (MARIZYME INC, Filed With SEC on October 12, 2023)
- Waiver and Consent between Marizyme, Inc. and Allesia Solimeo, dated as of July 20, 2023 (MARIZYME INC, Filed With SEC on October 12, 2023)
- Waiver and Consent between Marizyme, Inc. and Bologna Family Restaurant Spa, dated as of June 5, 2023 (MARIZYME INC, Filed With SEC on October 12, 2023)
- Consent and Waiver, dated September 22, 2023, between Qualigen Therapeutics, Inc. and Alpha Capital Anstalt (RITTER PHARMACEUTICALS INC, Filed With SEC on September 28, 2023)
- Limited Waiver between the Company and 3i, LP (Allarity Therapeutics, Inc., Filed With SEC on September 15, 2023)
- Waiver and Consent between Marizyme, Inc. and Waichun Logistics Technology Ltd, dated as of April 12, 2023 (MARIZYME INC, Filed With SEC on August 18, 2023)
- Waiver Agreement between Catalyst Biosciences, Inc. and Ms. Seline Miller, dated January 17, 2023 (CATALYST BIOSCIENCES, INC., Filed With SEC on August 14, 2023)
- Waiver Agreement between Catalyst Biosciences, Inc. and Dr. Grant Blouse, dated January 14, 2023 (CATALYST BIOSCIENCES, INC., Filed With SEC on August 14, 2023)
- Waiver Agreement between Catalyst Biosciences, Inc. and Dr. Nassim Usman, dated January 17, 2023 (CATALYST BIOSCIENCES, INC., Filed With SEC on August 14, 2023)
- Waiver and Second Amendment to Agreement, dated effective as of April 27, 2023, by and between Company and Coalition for Epidemic Preparedness Innovations (DYNAVAX TECHNOLOGIES CORP, Filed With SEC on August 3, 2023)
- Waiver, dated as of April 27, 2023, by and among Cerevel Therapeutics Holdings, Inc. and the investors party thereto (ARYA Sciences Acquisition Corp II, Filed With SEC on August 2, 2023)
- 3i, LP - Limited Waiver and Amendment Agreement (Allarity Therapeutics, Inc., Filed With SEC on June 7, 2023)
- Form of Limited Waiver and Amendment Agreement (Allarity Therapeutics, Inc., Filed With SEC on June 7, 2023)
- Waiver Agreement between Catalyst Biosciences, Inc. and Ms. Seline Miller, dated January 17, 2023 (CATALYST BIOSCIENCES, INC., Filed With SEC on May 15, 2023)
- Waiver Agreement between Catalyst Biosciences, Inc. and Dr. Grant Blouse, dated January 14, 2023 (CATALYST BIOSCIENCES, INC., Filed With SEC on May 15, 2023)
- Waiver Agreement between Catalyst Biosciences, Inc. and Dr. Nassim Usman, dated January 17, 2023 (CATALYST BIOSCIENCES, INC., Filed With SEC on May 15, 2023)
- Limited Waiver Agreement (Allarity Therapeutics, Inc., Filed With SEC on April 25, 2023)
- Limited Waiver Agreement (Allarity Therapeutics, Inc., Filed With SEC on February 28, 2023)
- Waiver and Consent between Marizyme, Inc. and Viner Total Investments Fund, dated January 9, 2023 (MARIZYME INC, Filed With SEC on January 17, 2023)
- Form of Limited Waiver and Consent between Marizyme, Inc. and certain investors (MARIZYME INC, Filed With SEC on November 2, 2022)
- Waiver, dated July 22, 2022, between Marizyme, Inc. and Waichun Logistics Technology Limited (MARIZYME INC, Filed With SEC on November 2, 2022)
- Waiver, dated July 22, 2022, between Marizyme, Inc. and Viner Total Investments Fund (MARIZYME INC, Filed With SEC on November 2, 2022)
- Amendment, Consent and Waiver Agreement, dated as of October 23, 2022, by and between the Company and Ricky Neumann (Orgenesis Inc., Filed With SEC on October 27, 2022)
- Form of First Amendment and Waiver effective as of August 31, 2022 (ADiTx Therapeutics, Inc., Filed With SEC on September 7, 2022)
- Waiver dated June 13, 2022 (TENAX THERAPEUTICS, INC., Filed With SEC on June 16, 2022)
- Waiver and Amendment Letter, dated May 23, 2022 (OPGEN INC, Filed With SEC on May 24, 2022)
- Form of Waiver Agreement (AzurRx BioPharma, Inc., Filed With SEC on May 13, 2022)
- Form of Waiver (CLEVELAND BIOLABS INC, Filed With SEC on March 22, 2022)
- Form of Waiver (AzurRx BioPharma, Inc., Filed With SEC on February 7, 2022)
- Waiver and Amendment between Qualigen Therapeutics, Inc. and Alpha Capital Anstalt, dated November 29, 2021 (RITTER PHARMACEUTICALS INC, Filed With SEC on December 1, 2021)
